In a move with global implications, China is on the verge of approving Russia\u2019s cancer vaccine, a breakthrough that could challenge the dominance of Western pharmaceutical companies and disrupt a $2.6 trillion industry.
In a move with global implications, China is on the verge of approving Russia\u2019s cancer vaccine, a breakthrough that could challenge the dominance of Western pharmaceutical companies and disrupt a $2.6 trillion industry.
